Oslo, September 11, 2025 - Observe Medical ("the Company" or "Observe Medical") has initiated activities in 2 additional South American markets, Brazil and Colombia, representing a combined population of approximately 260 million.

With this expansion, the Company's UnoMeter™ branded product family is now represented in 43 countries worldwide.

Jørgen Mann, CEO of Observe Medical, commented: "Our UnoMeter™ branded product family is now represented in 43 countries, and strengthens our global footprint. The situation of having distributors that are now actively working with our products in Europe, South America, and Asia confirms our continuous experience that our UnoMeter™ product family is in demand across a very large geography. The focus of our distributors is now on winning local tenders and converting hospitals back to the UnoMeter™ product range."

Please be reminded that Observe Medical will host a trading update webcast on 23 September 2025 at 09:00 CEST.

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.